Article

CMS decision allows beneficiary access to toric IOL

Baltimore-Medicare beneficiaries undergoing cataract surgery now have the option of choosing a toric IOL instead of a conventional lens following a ruling by the Centers for Medicare and Medicaid Services (CMS).

Baltimore-Medicare beneficiaries undergoing cataract surgery now have the option of choosing a toric IOL instead of a conventional lens following a ruling by the Centers for Medicare and Medicaid Services (CMS).

Those beneficiaries opting to receive the astigmatism-correcting implant will be responsible for paying the difference between the cost of that IOL and Medicare’s reimbursement as well as the additional cost associated with insertion of the toric lens.

The ruling took effect Jan. 22 and is available at

www.cms.hhs.gov/rulings/downloads/CMS1536R.pdf.

CMS will provide additional guidance, including a list of the specific IOLs affected, to Medicare contractors.


Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.